Cantitate/Preț
Produs
Total produse
Vezi coșul
Anxiety Disorders de Kerry J. Ressler

Anxiety Disorders: Primer On

Editat de Kerry J. Ressler, Daniel S. Pine, Barbara Olasov Rothbaum
en Limba Engleză Paperback – 21 mai 2015

Observăm că managementul clinic al patologiilor psihiatrice a suferit transformări profunde odată cu adoptarea noilor criterii de diagnostic. În acest context, Anxiety Disorders, sub redacția lui Kerry J. Ressler, Daniel S. Pine și Barbara Olasov Rothbaum, se impune ca o resursă esențială prin actualizarea recomandărilor terapeutice conform ghidurilor DSM-5. Ne-a atras atenția modul în care autorii reușesc să pună în dialog neuroștiințele moderne cu practica de cabinet, oferind o perspectivă integrată asupra modului în care tratamentul influențează direct neurocircuitul cerebral.

Suntem de părere că forța acestui volum rezidă în echilibrul dintre rigoarea cercetării genetice și aplicabilitatea clinică imediată. Spre deosebire de abordările pur descriptive, lucrarea explorează mecanismele fiziopatologice comune care explică de ce anxietatea coexistă atât de frecvent cu depresia sau abuzul de substanțe. Manual de referință comparabil cu The Cambridge Handbook of Anxiety and Related Disorders, dar actualizat conform ghidurilor recente din DSM-5, volumul de față prioritizează „necesarul de cunoștințe” pentru o diagnosticare precisă, eliminând redundanțele teoretice în favoarea unor sinteze clare.

Structura capitolelor, care include studii de caz detaliate, permite clinicienilor să identifice rapid biomarkeri de boală și predictori biologici pentru succesul tratamentului. Este o resursă care depășește granițele unui simplu manual de psihiatrie, adresându-se complexității pacientului contemporan prin prisma inovațiilor din neuroimagistică și epigenetică.

Citește tot Restrânge

Din seria Primer On

Preț: 83673 lei

Preț vechi: 115769 lei
-28%

Puncte Express: 1255

Carte tipărită la comandă

Livrare economică 04-10 iunie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă

Specificații

ISBN-13: 9780199395125
ISBN-10: 0199395128
Pagini: 528
Dimensiuni: 175 x 249 x 28 mm
Greutate: 0.93 kg
Editura: Oxford University Press
Colecția OUP USA
Seria Primer On

Locul publicării:New York, United States

De ce să citești această carte

Recomandăm această lucrare medicilor rezidenți și specialiștilor psihiatri care au nevoie de o punte solidă între noile criterii DSM-5 și practica clinică. Cititorul câștigă o înțelegere profundă a neurobiologiei anxietății, transformând datele abstracte despre biomarkeri în strategii de tratament personalizate. Este instrumentul ideal pentru a naviga comorbiditățile complexe dintre anxietate și depresie, oferind claritate diagnostică într-un format dens, dar extrem de lizibil.

Despre autor

Echipa editorială este formată din figuri proeminente ale psihiatriei americane. Kerry J. Ressler este un expert recunoscut în neurobiologia fricii și a PTSD-ului, fiind implicat în cercetări de pionierat la Harvard Medical School. Daniel S. Pine coordonează secția de neuroștiințe clinice la National Institute of Mental Health (NIMH), focusându-se pe anxietatea pediatrică. Barbara Olasov Rothbaum este specialistă în tratamentul tulburărilor post-traumatice și pionier în utilizarea realității virtuale în terapie. Împreună, aceștia reunesc expertiza clinică a Oxford University Press pentru a oferi o viziune multidisciplinară asupra sănătății mintale.

Descriere

Anxiety affects millions, manifesting as generalized anxiety disorder (GAD), obsessive compulsive disorder, panic disorder, phobias, post-traumatic-stress disorder (PTSD), and social anxiety disorder. Not only are anxiety disorders common, but they are also crippling, frequently co-occurring and predict high risk for depressive disorders. Shared mechanisms may explain the overlapping features of many anxiety disorders and account for associations with other highly-impairing conditions, such as major depression and substance use. Beyond risk for specific disorders, anxiety also predicts a number of other adverse outcomes, including suicidal behavior, medical problems, social, and economic difficulties. Conversely, disorder-specific mechanisms may also exist and explain the unique features of each syndrome. Thus, it is important to understand both shared and specific aspects of anxiety. The Primer on Anxiety Disorders provides early-stage practitioners and trainees, as well as seasoned clinicians and researchers, with need-to-know knowledge on diagnosis and treatment. Clinical cases are used throughout the book to enhance understanding of and illustrate specific disorders, comorbid conditions and clinical issues. To facilitate an integrative approach, content allows clinicians to understand patient characteristics and tailor interventions. The integrated approach of each chapter includes recent research on genetics and neuroscience to understand the mechanisms of anxiety disorders, focusing on the forthcoming new nosology in DSM-5. Chapters further integrate innovative advances in clinical research providing research on a range of discoveries regarding biomarkers of illness, biological predictors of treatments and the effect of treatment on neurocircuitry.

Recenzii

All clinicians and clinical scientists working in anxiety disorders who would like a vision of where the field will be in 5 to 10 years should read this Primer. With three of the leading clinical investigators in the world as Editors, and with a first-rate roster of contributors covering all the latest findings from neurotransmitter underpinnings of drug treatments to the neuroscience of psychological treatments, readers can preview likely changes in diagnosis, assessment, and treatment in the years to come. Most importantly, we get a glimpse of a future in which we can individualize treatment based on a sound set of scientifically validated predictors of outcome. A must read!" - David H. Barlow PhD, ABPP, Professor of Psychology and Psychiatry, Boston University, Founder and Director Emeritus, Center for Anxiety and Related Disorders, Boston, MA
The study of anxiety, once the foundational concept for all psychopathology, maps the path for the future of all psychiatric neuroscience and psychobiology, revealing the rich interplay of nature, nurture and development, and yielding therapeutic advances in psychotherapies, psychopharmacology and neurotherapeutics. The publishers, editors and authors of this volume, and the pioneering organization that has brought them together, the ADAA, have delivered a comprehensive, essential and useful volume for the field." - Jerrold F. Rosenbaum, MD, Chief of Psychiatry, Massachusetts General Hospital; Stanley Cobb Professor of Psychiatry, Harvard Medical School, Boston, MA
Among the book's many strengths are its readability, the focus on the important, need-to-know material, and comprehensive summaries of cited research.

Notă biografică

Kerry J. Ressler, Professor of Psychiatry and Behavioral Sciences at Emory University, received his B.S. degree in molecular biology from M.I.T., and his M.D./Ph.D. from Harvard Medical School. His work focuses on translational research bridging molecular neurobiology in animal models with human genetic research. His basic and clinical research examines neurobiological, molecular, genetic and behavioral processes that underlie fear related processing and Posttraumatic Stress Disorder.Dr. Daniel S. Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders. Currently, his group examines the degree to which mood and anxiety disorders in children and adolescents are associated with abnormalities in the amygdala, prefrontal cortex, and brain regions that modulate these structures.Barbara Olasov Rothbaum, Ph.D. is a professor in psychiatry and Associate Vice Chair of Clinical Research at the Emory School of Medicine in the Department of Psychiatry and Behavioral Sciences and director of the Trauma and Anxiety Recovery Program at Emory. Dr. Rothbaum specializes in research on the treatment of individuals with anxiety disorders, particularly focusing on Posttraumatic Stress Disorder (PTSD).